A quality-of-life study was carried out to test the hypothesis that melanoma patients treated with a 3-cm margin of excision suffer greater impairment of their quality of life than those treated with a 1-cm margin. The secondary aim was to determine the predictors of a poor patient perception of their excision scar. A postal questionnaire study was carried out using Hospital Anxiety and Depression (HAD), Psychosocial Adjustment of Illness Scale–Self-Report (PAIS-SR), Medical Outcomes Survey–Short Form 36 (MOS-SF36), and the Cassileth Scar questionnaires. Data were collected from 426 of the 537 patients who were mailed the questionnaires (response rate 79%). Fourteen percent had clinically significant anxiety and 5% had significant depressio...
"Malignant melanoma writes its message in the skin with its own ink ... some see, but do not compreh...
The rising incidence of Non Melanoma Skin Cancers (NMSC) leads to a high number of surgical procedur...
Background: Reliable evidence to guide the management of melanoma in situ (MIS) and minimize the ris...
A quality-of-life study was carried out to test the hypothesis that melanoma patients treated with a...
Background The necessary margin of excision for cutaneous melanomas greater than 2 mm in thickness i...
SummaryBackgroundThe necessary margin of excision for cutaneous melanomas greater than 2 mm in thick...
Background: The optimal surgical excision margins are uncertain for patients with thick (>2 mm) loca...
Background: In the past there has been controversy concerning the necessary margin of excision for c...
OBJECTIVE: This study was designed to determine the minimum safe pathologic excision margin for prim...
Wide local excision of the primary tumour is the mainstay of treatment for melanoma patients. The ai...
Background Optimum surgical resection margins for patients with clinical stage IIA-C cutaneous melan...
OBJECTIVE: To quantify the impact of excision margins on disease-specific survival of patients with ...
Promoting standardization and quality assurance (QA) in oncology on the strength of real-world data ...
BACKGROUND Most guidelines recommend at least 2-cm excision margin for melanomas thicker than 2 m...
We estimated the potential benefit of reducing rates of inadequate excision margins in the treatment...
"Malignant melanoma writes its message in the skin with its own ink ... some see, but do not compreh...
The rising incidence of Non Melanoma Skin Cancers (NMSC) leads to a high number of surgical procedur...
Background: Reliable evidence to guide the management of melanoma in situ (MIS) and minimize the ris...
A quality-of-life study was carried out to test the hypothesis that melanoma patients treated with a...
Background The necessary margin of excision for cutaneous melanomas greater than 2 mm in thickness i...
SummaryBackgroundThe necessary margin of excision for cutaneous melanomas greater than 2 mm in thick...
Background: The optimal surgical excision margins are uncertain for patients with thick (>2 mm) loca...
Background: In the past there has been controversy concerning the necessary margin of excision for c...
OBJECTIVE: This study was designed to determine the minimum safe pathologic excision margin for prim...
Wide local excision of the primary tumour is the mainstay of treatment for melanoma patients. The ai...
Background Optimum surgical resection margins for patients with clinical stage IIA-C cutaneous melan...
OBJECTIVE: To quantify the impact of excision margins on disease-specific survival of patients with ...
Promoting standardization and quality assurance (QA) in oncology on the strength of real-world data ...
BACKGROUND Most guidelines recommend at least 2-cm excision margin for melanomas thicker than 2 m...
We estimated the potential benefit of reducing rates of inadequate excision margins in the treatment...
"Malignant melanoma writes its message in the skin with its own ink ... some see, but do not compreh...
The rising incidence of Non Melanoma Skin Cancers (NMSC) leads to a high number of surgical procedur...
Background: Reliable evidence to guide the management of melanoma in situ (MIS) and minimize the ris...